UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Atezolizumab plus bevacizumab in Child-Pugh B advanced hepatocellular carcinoma patients

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.397-397

2022

Volltextzugriff (PDF)

Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events

Liver international, 2020-09, Vol.40 (9), p.2263-2271

2020

Volltextzugriff (PDF)

High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma

JHEP reports, 2023-04, Vol.5 (4), p.100672, Article 100672

2023

Volltextzugriff (PDF)

Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma

Therapeutic advances in medical oncology, 2023-01, Vol.15, p.175883592211485-17588359221148541

2023

Volltextzugriff (PDF)

Numerical Investigation of High-Purity Entangled Photon-Pair Generation in Ba3Mg3(BO3)3F3 Crystals

Crystals (Basel), 2020-12, Vol.10 (12), p.1164

2020

Volltextzugriff (PDF)

Theoretical Investigation of the Generation of Broad Spectrum Second Harmonics in Pna21-Ba₃Mg₃(BO₃)₃F₃ Crystals

Current Optics and Photonics, 2021, 5(4), , pp.458-465

2021

Volltextzugriff (PDF)

Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint Inhibitors

Cancers, 2022-07, Vol.14 (14), p.3440

2022

Volltextzugriff (PDF)

Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group

Therapeutic advances in medical oncology, 2019-08, Vol.11, p.1758835919871126-1758835919871126

2019

Volltextzugriff (PDF)

Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular Carcinoma

Liver cancer (Basel ), 2024-02, Vol.13 (1), p.89-98

2024

Volltextzugriff (PDF)

Management following the first confirmed case of SARS-CoV-2 in a domestic cat associated with a massive outbreak in South Korea

One health, 2021-12, Vol.13, p.100328-100328, Article 100328

2021

Volltextzugriff (PDF)

A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice

Oncoimmunology, 2018-05, Vol.7 (5), p.e1421890-e1421890

2018

Volltextzugriff (PDF)

Genomic and probiotic characterization of SJP-SNU strain of Pichia kudriavzevii

AMB Express, 2018-05, Vol.8 (1), p.80-9, Article 80

2018

Volltextzugriff (PDF)

Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study

The lancet oncology, 2021-11, Vol.22 (11), p.1560-1572

2021

Volltextzugriff (PDF)

Effect of the fourth nucleotide at the 3" end of neuraminidase and matrix viral genomic RNA on the pathogenicity of influenza virus A/PR/8/34

Journal of Veterinary Science, 2017, 18(0), , pp.307-313

2017

Volltextzugriff (PDF)

Association of High Levels of Antidrug Antibodies Against Atezolizumab With Clinical Outcomes and T-Cell Responses in Patients With Hepatocellular Carcinoma

JAMA oncology, 2022-12, Vol.8 (12), p.1825

2022

Volltextzugriff (PDF)

Correlation of high serum interleukin-6 with clinical outcome and T cell response in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.596-596

2023

Volltextzugriff (PDF)

Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma

Liver international, 2022-03, Vol.42 (3), p.674-681

2022

Volltextzugriff (PDF)

High atezolizumab antidrug antibody levels are associated with unfavorable clinical outcomes and diminished T cell responses following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4105-4105

2022

Volltextzugriff (PDF)

Study on a polarization-entangled photon-pair source based on niobium-doped potassium titanyl phosphate

Journal of the Korean Physical Society, 2021, 78(9), , pp.776-783

2021

Volltextzugriff (PDF)

Sketching North Korea: The Representations of North Korea Based on Newspaper Big Data, ‘Trends 21’

Review of North Korean Studies, 2017-08, Vol.20 (2), p.7-37

2017

Volltextzugriff (PDF)

Comparison of prophylactic effects for chemotherapy induced neutropenia between same-day versus next-day administration of pegteograstim (Neurapeg®) in patients treated with chemotherapy regimen composed of day 1 intensive myleosuppressive agent: A randomized phase III clinical trial

Medicine (Baltimore), 2023-05, Vol.102 (20), p.e33638-e33638

2023

Volltextzugriff (PDF)

Theoretical Investigation of the Generation of Broad Spectrum Second Harmonics in Pna2 1 -Ba 3 Mg 3 (BO 3 ) 3 F 3 Crystals

Current optics and photonics, 2021, Vol.5 (4), p.458-465

2021

Volltextzugriff (PDF)

Serum vitamin D 3 levels and overall survival (OS) in patients (pts) with advanced biliary tract cancer (BTC): Analysis of the NIFTY trial cohort

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.613-613

2023

Volltextzugriff (PDF)

ctDNA as a biomarker in phase II study of tepotinib in advanced solid cancers with MET exon 14 skipping mutation or amplification (KCSG AL19-17)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.3050-3050

2024

Volltextzugriff (PDF)

1 – 25 von 201

Suche als RSS-Feed

Aktive Filter

ThemaTechnology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(149)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Atezolizumab plus bevacizumab in Child-Pugh B advanced hepatocellular carcinoma patients

Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events

High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma

Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma

Numerical Investigation of High-Purity Entangled Photon-Pair Generation in Ba3Mg3(BO3)3F3 Crystals

Theoretical Investigation of the Generation of Broad Spectrum Second Harmonics in Pna21-Ba₃Mg₃(BO₃)₃F₃ Crystals

Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint Inhibitors

Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group

Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular Carcinoma

Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries

Management following the first confirmed case of SARS-CoV-2 in a domestic cat associated with a massive outbreak in South Korea

A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice

Genomic and probiotic characterization of SJP-SNU strain of Pichia kudriavzevii

Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study

Effect of the fourth nucleotide at the 3" end of neuraminidase and matrix viral genomic RNA on the pathogenicity of influenza virus A/PR/8/34

Association of High Levels of Antidrug Antibodies Against Atezolizumab With Clinical Outcomes and T-Cell Responses in Patients With Hepatocellular Carcinoma

Correlation of high serum interleukin-6 with clinical outcome and T cell response in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab

Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma

High atezolizumab antidrug antibody levels are associated with unfavorable clinical outcomes and diminished T cell responses following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma

Study on a polarization-entangled photon-pair source based on niobium-doped potassium titanyl phosphate

Sketching North Korea: The Representations of North Korea Based on Newspaper Big Data, ‘Trends 21’

Comparison of prophylactic effects for chemotherapy induced neutropenia between same-day versus next-day administration of pegteograstim (Neurapeg®) in patients treated with chemotherapy regimen composed of day 1 intensive myleosuppressive agent: A randomized phase III clinical trial

Theoretical Investigation of the Generation of Broad Spectrum Second Harmonics in Pna2 1 -Ba 3 Mg 3 (BO 3 ) 3 F 3 Crystals

Serum vitamin D 3 levels and overall survival (OS) in patients (pts) with advanced biliary tract cancer (BTC): Analysis of the NIFTY trial cohort

ctDNA as a biomarker in phase II study of tepotinib in advanced solid cancers with MET exon 14 skipping mutation or amplification (KCSG AL19-17)

Aktive Filter

Suchergebnisse filtern